Next 10 |
2024-06-24 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-09 05:15:00 ET Summary Structure Therapeutics raises $476 million through an offering of its ADSs after announcing positive clinical results for its obesity drug. Suzhou Alphamab Oncology partners with ArriVent BioPharma to develop antibody drug conjugates, potentially rec...
2024-06-04 11:20:58 ET Summary Schrödinger is a hybrid biopharma company specializing in physics-based computational chemistry and traditional drug development. The company aims to utilize computational methods to create better drug candidates and improve strategic decision-m...
2024-05-27 09:40:00 ET Summary Google DeepMind and Isomorphic Labs have recently unveiled an exciting new breakthrough, AlphaFold 3. AlphaFold 3 employs advanced AI algorithms to accurately model molecular structures and interactions. Beyond drug discovery, AlphaFold 3’...
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the Jefferies Healthcare Conference. The live presentation will take place on Wedne...
2024-05-15 08:45:00 ET As you may have heard, there's a new trend in biotech lingo wherein companies call themselves "TechBio" rather than "biotech" to emphasize their forward-thinking about the role of information technology. Biotechs like Ginkgo Bioworks (NYSE: DNA) , Recursion ...
2024-05-10 14:13:46 ET More on Alphabet, Recursion, etc. Recursion Pharmaceuticals, Inc. (RXRX) Q1 2024 Earnings Call Transcript Bronte Capital - Alphabet: Could Not Find Anything We Liked More Google: The Recent Surge Is Far From Over CrowdStrike, Google exp...
2024-05-07 12:30:13 ET Summary Market conditions remain tough, which is weighing on demand for both Schrödinger's software and drug discovery services. Investors continue to punish Schrödinger's investments in drug discovery, despite the company progressing drug candidat...
2024-05-02 15:04:30 ET More on Bristol Myers, Schrödinger Schrödinger, Inc. (SDGR) Q1 2024 Earnings Call Transcript Schrödinger, Inc. 2024 Q1 - Results - Earnings Call Presentation Bristol Myers Squibb: Tough Times Continue Schrodinger tumbles ...
2024-05-01 20:28:09 ET Schrödinger, Inc. (SDGR) Q1 2024 Earnings Conference Call May 01, 2024, 16:30 PM ET Company Participants Ramy Farid - President and CEO Geoff Porges - CFO Karen Akinsanya - President R&D, Therapeutics Jaren Madden - Senior Vice...
News, Short Squeeze, Breakout and More Instantly...
2024-06-24 12:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in a fireside chat at the Jefferies Healthcare Conference. The live presentation will take place on Wedne...
2024-05-15 08:45:00 ET As you may have heard, there's a new trend in biotech lingo wherein companies call themselves "TechBio" rather than "biotech" to emphasize their forward-thinking about the role of information technology. Biotechs like Ginkgo Bioworks (NYSE: DNA) , Recursion ...